Rising Biosciences (Rising Biosciences) Gross Margin % : 0.00% (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Rising Biosciences's Gross Profit for the three months ended in . 20 was $0.00 Mil. Rising Biosciences's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Rising Biosciences's Gross Margin % for the quarter that ended in . 20 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for Rising Biosciences's Gross Margin % or its related term are showing as below:

RBII's Gross Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 47.04
* Ranked among companies with meaningful Gross Margin % only.

Rising Biosciences had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Rising Biosciences was 0.00% per year.

Rising Biosciences Gross Margin % Historical Data

The historical data trend for Rising Biosciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Gross Margin % Chart

Rising Biosciences Annual Data

Trend

Gross Margin %

Rising Biosciences Quarterly Data

Gross Margin %

Competitive Comparison of Rising Biosciences's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Gross Margin % falls into.

Rising Biosciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Rising Biosciences's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )	=	Gross Profit (A: . 20 )	/	Revenue (A: . 20 )
	=	0	/
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	( - )	/
	=	N/A %

Rising Biosciences's Gross Margin for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )	=	Gross Profit (Q: . 20 )	/	Revenue (Q: . 20 )
	=	0	/
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	( - )	/
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Rising Biosciences (GREY:RBII) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Rising Biosciences had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Rising Biosciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Gross Margin %

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.